The disease arises from either reduced insulin secretion by pancreatic β-cells (type 1 diabetes) or impaired tissue responsiveness to insulin (type 2 diabetes [T2D]) (Kumar et al. 2020). The gene discussed is INS; the disease is type 2 diabetes mellitus.